Bioventus (BVS) Financial Statements & Analysis

Bioventus (BVS) Income Statement

Bioventus reported revenue of $568.09M in fiscal 2025 (fiscal year ended Dec 31, 2025), down 0.9% from $573.28M a year earlier. Net income was $22.73M, a net margin of 4.0%. Gross margin was 68.3% and operating margin 9.9%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $153.21M, up 3.8% from the same quarter a year earlier.

Bioventus Income Statement Analysis

Values in millions USD

Income Statement Balance Sheet Cash Flow Ratios

Scale:

Scroll to see more

Bioventus Inc. income statement - Annual data in millions USD
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period ending	Dec 2025	Dec 2024	Dec 2023	Mar 2023	Dec 2022	Dec 2021	Dec 2020	Dec 2019	Dec 2018
Revenue & Gross Profit
Revenue	568.09	573.28	512.35	512.12	512.12	430.90	321.16	340.14	319.18
Cost of Revenue	179.93	185.05	184.15	181.04	181.04	128.19	87.64	90.94	84.17
Gross Profit	388.16	388.23	328.19	331.08	331.08	302.71	233.52	249.21	235.01
Operating Expenses
Research & Development	12.11	13.95	13.45	23.85	23.85	19.04	11.20	11.06	8.10
Selling, General & Administrative	314.03	343.80	303.88	332.13	332.13	254.25	193.08	198.48	191.67
Operating Expenses	331.87	365.40	409.92	498.31	488.57	282.28	212.28	218.01	209.51
Operating Income	56.29	22.83	-81.73	-167.23	-167.23	12.06	21.24	31.19	25.50
Other Income/Expense
Interest Income	0.00	0.00	0.00	0.00	6.40	2.73	0.00	0.00	0.00
Interest Expense	26.49	38.79	40.68	12.02	-18.42	-3.84	9.75	21.58	19.17
Other Income/Expense	-4.10	-36.38	-39.39	-21.79	-24.04	-2.22	-5.32	-21.50	-19.40
Income
Income Before Tax	25.71	-52.34	-121.11	-189.03	-189.03	9.49	15.91	9.69	6.11
Income Tax Expense	-1.57	-5.29	0.09	-44.37	-44.37	-1.97	1.19	1.58	1.66
Net Income	22.73	-36.13	-156.23	-158.70	-158.70	19.38	16.41	6.85	-12.21
Net Income - Continuous Operations	27.27	-47.05	-156.23	-158.70	-144.65	11.45	16.41	6.85	-12.21
Net Income - Discontinued Operations	-	-	-74.43	-	-68.74	-1.87	-	-	-
EBITDA	99.21	36.01	-23.07	-121.61	-4.68	41.52	54.31	61.58	54.52
EBIT	52.20	-13.55	-80.44	-	-34.66	21.05	21.80	-	-
Depreciation & Amortization	5.73	7.65	57.37	55.40	29.97	20.47	28.64	30.32	29.24
Earnings Per Share
Basic EPS	-	-1.00	-2.00	-3.00	-3.00	-	-	-	-
Diluted EPS	-	-1.00	-2.00	-3.00	-3.00	-	-	-	-
Basic Shares Outstanding	66.62	64.55	62.65	61.39	61.39	45.47	37.70	56.83	56.83
Diluted Shares Outstanding	68.91	64.55	62.65	61.39	61.39	45.47	37.70	56.83	56.83

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About Bioventus Financial Statements

What was Bioventus's revenue in fiscal 2025?

Bioventus reported revenue of $568.09M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was down 0.9% from $573.28M a year earlier.

Is Bioventus profitable?

Yes. Bioventus earned net income of $22.73M in fiscal 2025, a net margin of 4.0%. In fiscal 2024 it lost $36.13M.

What is Bioventus's operating margin?

Bioventus's operating income was $56.29M on revenue of $568.09M in fiscal 2025, an operating margin of 9.9%, compared with 4.0% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition